EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA AND ITS ASSOCIATION WITH BASELINE WHITE BLOOD CELL COUNT AND SPLEEN SIZE

EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA AND ITS ASSOCIATION WITH BASELINE WHITE BLOOD CELL COUNT AND SPLEEN SIZE

Objectives: To determine the frequency of early molecular response in patients of chronic myeloid leukemia treated with Imatinib and its association with baseline white blood cell (WBC) count and spleen size. Study Design: Cross sectional study. Place and Duration of Study: Combined Military Hosp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Abdul Ali Wajid, Mansoor Zeeshan, Faisal Mehmood, Imtenan Sharif, Muhammad Umair, Aamira Ali
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2018
Materias:
chronic myeloid leukemia
imatinib
Medicine
R
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/d08677138f37425ea0848e8e5bae5e9c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares